Novo Nordisk and Evotec launch translational drug discovery accelerator
The partnership will help advance preclinical concept in the cardiometabolic disorder space from four academic institutions.
The partnership will help advance preclinical concept in the cardiometabolic disorder space from four academic institutions.
What's Your Reaction?
